Grace Therapeutics, Inc. · NASDAQ:GRCE

Nantahala Capital Management, LLC reported a 6.75% stake in Grace Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Nantahala Capital Management, LLC reported a 6.75% stake in Grace Therapeutics, Inc., 1,178,203 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
6.75%
Shares
1,178,203
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC6.75%1,178,203
Wilmot B. Harkey6.75%1,178,203
Daniel Mack6.75%1,178,203

Source

View original at SEC

Related